Divarasib

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

Divarasib

Jan 10, 2024, 18:21 | Blog

Top Precision Oncology articles of 2023 by Vivek Subbiah

Vivek Subbiah shared on X/Twitter: "By popular demand delighted to share the 'Top Precision Oncology…

Aug 27, 2023, 18:58 | Insight

Vivek Subbiah: The 3rd KRAS G12C kid on the block.

According to Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute:…

Aug 27, 2023, 18:50 | Insight

Anirban Maitra: The phase 1 data of Genentech’s KRAS G12C inhibitor Divarasib was published yesterday in NEJM.

In a Twitter post by Anirban Maitra, a Professor of Pathology and Translational Molecular Pathology,…

All: 3 Posts: 1 - 100

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

'

King Charles III Hospitalized Following Side Effects from Cancer Treatment

'

Keith T. Flaherty has been elected as the AACR President-Elect for 2025-2026

'

MARIPOSA trial results presented at ELCC25 - BREAKING from Paris

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023